US › Healthcare

STRATA Skin Sciences Inc (SSKN)

US · Healthcare · Medical Devices

$0.010.00%
Last close · 2026-08-04

Latest quarter · ended 2025-12-31

Revenue
$9.3M
Revenue YoY
-3.0%
Net profit
$58,000
Profit YoY
+101.3%
EPS
$-0.36
EPS estimate
$-0.24
Net margin
0.6%

EPS came in at -0.36 against a street estimate of -0.24 — a miss of 50.0%.

Key statistics

Market cap
$32,385
Forward P/E
188.7
P/B
0.01
Book value
$0.49
EPS (TTM)
$-1.35
52-week high
$3.86
52-week low
$0.00
50-day MA
$0.09
200-day MA
$0.63
Beta
-0.05

Analyst view

Analysts rate STRATA Skin Sciences Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $10.80.

Shareholding

Insiders
9.97%
Institutions
25.38%

Largest institutional holders

FundStake
Creative Planning Inc0.00%
22NW, LP0.00%
Hanson Mcclain Inc0.00%
BlackRock Inc0.00%
Tower Research Capital LLC0.00%
Financial Perspectives Inc0.00%
UBS Group AG0.00%
Apollon Wealth Management, LLC0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for STRATA Skin Sciences Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.